Upstate Medical University

Achieving Manufacturing Readiness, Using a Time-Tested Approach that Speeds Product Development Progress

Achieving Manufacturing Readiness, Using a Time-tested Approach that Speeds Product Development Progress

November 8, 3:00 – 4:00 p.m. EST

Mike Riedlinger, Managing Director, Tech Commercialization and Mike Marvin, Startup Manufacturing Program Coordinator, NextCorps

Register in advance for this meeting:

https://upstate.zoom.us/meeting/register/tJUvce-orT4jE9GLnUmcbgZeNyPLUV1qABY7  

This session is about uncovering and reducing product development risks from many issues, including those that are often invisible to innovators until they derail a startup business.  The Manufacturing Readiness Levels approach enables new product developers to efficiently identify, plan and execute the next steps required on the path to volume production. 

The presenters will provide information about using the “Manufacturing Readiness Levels” methodology to allow new product teams and inventors to objectively evaluate and execute their development progress from concept stage to controlled mass-production at market scale. Access to web-based tools, additional informational materials and templates to assist with advancing manufacturing readiness will also be made available to session attendees along with connections to manufacturing and financial resources in New York State that can assist new product teams that use the methodology.

Mike Riedlinger
Managing Director, Tech Commercialization
mike.riedlinger@nextcorps.org

Mike Marvin
Startup Manufacturing Program Coordinator
mike.marvin@nextcorps.org

NextCorps has developed this program with funding from New York State and the National Institute for Standards and Technologies.  Over 100 new product teams and inventors that developed products for life sciences, medical applications and general consumer markets have participated in pilot sessions over the past five years.  Past participants have successfully brought their products to market and gained over $450 million in additional investment capital.